Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanna Bailey
Institution:
Moffitt Cancer Center
Observed institutions:
University of Utah,
Huntsman Cancer Institute,
Moffitt Cancer Center
ORCID:
0009-0005-9959-7162
Observed ORCID:
0009-0005-9959-7162
OpenAlex ID:
A5060979074
Panobinostat for the treatment of multiple myeloma: the evidence to date
2015
·
Sunil Sharma
, Hanna Bailey
, et al.
·
Journal of Blood Medicine
·
47
PDF
A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors
2016
·
Hanna Bailey
, Jordan P. McPherson
, et al.
·
Cancer Chemotherapy and Pharmacology
·
13
A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin
2015
·
Neeraj Agarwal
, Jordan P. McPherson
, et al.
·
Cancer Chemotherapy and Pharmacology
·
13
Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients
2025
·
Lilit Karapetyan
, Joel Kuriakose
, et al.
·
Transplantation and Cellular Therapy
·
7
Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
2023
·
Filip Ionescu
, Bijal D. Shah
, et al.
·
Blood
·
2
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
2025
·
Lilit Karapetyan
, Joel Kuriakose
, et al.
·
Frontiers in Immunology
·
1
PDF
Isatuximab and Belantamab Mafodotin: A Primer to an Evolving Multiple Myeloma Landscape
2021
·
Rebecca Gonzalez
, Hanna Bailey
, et al.
·
EMJ Hematology
·
1
PDF
Corrigendum to “Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients”
2026
·
Lilit Karapetyan
, Joel Kuriakose
, et al.
·
Transplantation and Cellular Therapy
Development of a Citrate Reaction Grading and Treatment Chart for Patients Undergoing Leukapheresis Procedures
2026
·
Amber Lebron
, Hanna Bailey
, et al.
·
Journal of Clinical Apheresis
PDF
Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee
2026
·
Lance A. Williams
, Kristin Gray
, et al.
·
Journal of Clinical Apheresis
Accelerated step-up dosing of glofitamab in rapidly progressive R/R DLBCL: a real-world cohort analysis
2026
·
Fnu Amisha
, Syeda Saba Kareem
, et al.
·
Blood Immunology & Cellular Therapy
Motixafortide Is Effective in Hematopoietic Progenitor Cell Mobilization in Multiple Myeloma Patients Treated with Quadruplet Therapy
2026
·
Hanna Bailey
, Elizabeth DiMaggio
, et al.
·
Transplantation and Cellular Therapy
Adverse Drug Effects Following Motixafortide for Hematopoietic Progenitor Cell Mobilization in Patients with Multiple Myeloma
2026
·
Elizabeth DiMaggio
, Hanna Bailey
, et al.
·
Transplantation and Cellular Therapy
Plerixafor Dosing in Obese Patients with Multiple Myeloma: A Single Center Experience
2025
·
Megan Vince
, Elizabeth DiMaggio
, et al.
·
Transplantation and Cellular Therapy
Dosing Strategies for Plerixafor in Patients with Multiple Myeloma with Renal Impairment: A Single Center Experience
2025
·
Megan Vince
, Elizabeth DiMaggio
, et al.
·
Transplantation and Cellular Therapy
Cladribine and Cyclophosphamide Lymphodepletion Prior to Brexucabtagene Autoleucel in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma
2023
·
Filip Ionescu
, Rawan Faramand
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
17
Citation count:
84
H-index:
4
I10-index:
3
Year
Topic
Type